Skip to content

This content is in French.

Gut microbiota: metabolites at the heart of cardiovascular risk

3 avril 2026

Gut microbiota: metabolites at the heart of cardiovascular risk

By Elodie Vaz | Published on April 3, 2026 | 4 min readCoronary heart disease remains the leading cause of mortality worldwide. Its development relies on a complex interplay of genetic, metabolic, and environmental factors. Among these, the role of the gut microbiota has attracted growing interest. Acting as a true metabolic organ, it produces a wide range of molecules capable of entering the bloo

By Elodie Vaz | Published on April 3, 2026 | 4 min read


Coronary heart disease remains the leading cause of mortality worldwide. Its development relies on a complex interplay of genetic, metabolic, and environmental factors. Among these, the role of the gut microbiota has attracted growing interest. Acting as a true metabolic organ, it produces a wide range of molecules capable of entering the bloodstream and influencing host physiology—sometimes in harmful ways.  

A study published on March 17 in PLOS Medicine aimed to better understand the links between microbial metabolites and the risk of coronary heart disease. The researchers sought to identify, using large-scale human data, metabolic signatures associated with the onset of this cardiovascular condition.

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Zheng Y, Yang JJ, Gupta DK, Herrington DM, Yu B, Nguyen NQH, et al. Circulating gut microbial metabolites and risk of coronary heart disease: A prospective multi-stage metabolomics study. PLoS Med. 2026;23(3):e1004750. doi:10.1371/journal.pmed.1004750

View the source